embecta to Participate in Investor Events
Embecta (Nasdaq: EMBC), a medical supplies company specializing in insulin delivery, has announced its participation in two major healthcare investor conferences in September 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Embecta (Nasdaq: EMBC), a medical supplies company specializing in insulin delivery, has announced its participation in two major healthcare investor conferences in September 2025.
At the 2025 Wells Fargo Healthcare Conference on September 4, management will host a fireside chat at 3:00 p.m. EDT and conduct one-on-one investor meetings at the Encore Boston Harbor Hotel. The company will also participate in the 2025 Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, hosting one-on-one investor meetings at the Sheraton New York Times Square.
Details
News Market Reaction – EMBC
On Aug 27, the first trading day after this news, EMBC closed 2.67% above the previous close.
Data tracked by StockTitan Argus for the Aug 27 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
2025 Wells Fargo Healthcare Conference
- Management will host a fireside session on Thursday, September 4, 2025, at 3:00 p.m. EDT and one-on-one investor meetings throughout the day at the Encore Boston Harbor Hotel, Boston.
2025 Morgan Stanley 23rd Annual Global Healthcare Conference
- Management will host one-on-one investor meetings on Tuesday, September 9, 2025, at Sheraton New York Times Square, New York City.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.